/
Adlai Nortye Group Ltd.
Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies.
Mentions
1 mention · latest on 10 Jul 2026
See which tracked investors hold Adlai Nortye Group Ltd. →Ownership and position changes on OwnershipTrace
| Value Hive PodcastPodcast | Seedy19: A 35x Return From Biotech Investing | - | 10 Jul 2026 |